
The life sciences and biotech industries are among the fastest-growing economies, with a focus on investments in technological health solutions. The sector is adopting technology to enhance patient care, lower costs, boost transparency, produce more, and discover novel treatments. It's important for stakeholders to understand that the industry is undergoing a transformation as a result of the digital era and that this involves more than just expediting the current process in a digital pipeline. To adopt business processes that weren't previously possible, it involves more than merely using software to carry out routine task. The goal of digital transformation is to create innovative plans for fundamentally changing current business procedures in a way that benefits the company.

The biopharmaceutical industry is undergoing a profound transformation driven by digital technologies, often referred to as Biopharma 4.0. This era of digitalization presents unprecedented opportunities to revolutionize research and development (R&D) processes, leading to accelerated drug discovery, enhanced operational efficiency, and improved patient outcomes.
To delve deeper into this transformative journey and explore strategies for successful implementation, we are pleased to announce IDBS Presents "Enabling Digital Transformation in R&D with Biopharma 4.0" conference in association with BlueTech Media.
CxO, VP, Directors, Heads, Managers of

Senior Vice President Discovery Services,
Syngene International Limited

Chief Scientific Officer,
Aurigene Oncology Limited

Fermentation R&D Head,
Biocon Ltd

Head of Biologicals Research & Development, Anthem Biosciences

Senior Vice President,
Microlabs Analytical Research Lab

Senior Director, Process Development and Manufacturing Sciences, Kemwell Biopharma

General Manager, Head of MSAT, Aragen Biologics

Senior Vice President & Head,
Shilpa Pharma Lifescience Limited

Vice President Managing Director Integrated Safety, IQVIA

R&D Director, Site Leader,
Life Sciences Group
Thermo Fisher Scientific, Inc.

Director - R&D and Manufacturing, Serum Institute of India

Assistant Director, Technology Transfer, R&D - Biotechnology Division, Lupin Ltd.

Former Head, Quality Control,
Haffkine Bio-Pharmaceutical Corporation ltd

Commercial Director- Asia, IDBS

Regional Sale Manager- India & SE ASIA, IDBS

Additional Director,
Serum Institute Of India

Asst General Manager, Gennova Biopharmaceuticals

Associate Research Director, Reliance Life Sciences

Asst. Director, Bio Assay Development (Biosimilar) Lupin Biotech

Chief Technology Officer - Biotechnology, Biophore India Pharmaceuticals Pvt. Limited

Sr. Data Scientist - Digital Products Development, IDBS

CEO, Urokul Institute, Ex Director, Haffkine Institute, Mumbai






















BlueTech Media LLP
Office no - 203, 2nd floor, Aditya Heritage, besides Rustomjee Elanza, Malad west, 400064
Copyright © 2025 BlueTech Media LLP - All Rights Reserved.
Designed by Whyte Wings Media
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.